IPWatchdog Daily Newsletter Highlights Charles R. Macedo, David Goldberg and Chandler Sturm’s IP Watchdog Article on Recent Amicus Brief From Askeladden

The August 3 IPWatchdog daily email newsletter highlighted Charley Macedo, David Goldberg and Chandler Sturm’s recent article for the publication on the amicus brief from Askeladden asking the U.S. Supreme Court to grant the U.S. Government’s petition to reconsider whether PTAB APJs are principal officers under the appointments clause. For background, on July 29, Askeladden […]

Charles R. Macedo, David Goldberg and Chandler Sturm Co-Author IP Watchdog Article on Askeladden Brief Asks SCOTUS to Grant U.S. Government’s Petition to Reconsider Whether PTAB APJs Are Principal Officers Under the Appointments Clause

On July 29, Askeladden LLC filed an amicus brief in support of the U.S. Government’s combined petition for a writ of certiorari in U.S. v. Arthrex, Inc., No. 19-1434.   In this IPWatchdog article, “Askeladden Brief Asks SCOTUS to Grant U.S. Government’s Petition to Reconsider Whether PTAB APJs Are Principal Officers Under the Appointments Clause,” […]

Recap of Charles R. Macedo’s World Congress Webinar on Innovations in Machine Learning and Challenges Associated with Protecting Computer Invented Innovations

On June 18, partner Charles Macedo and Daniel Dardani, Technology Licensing Officer at MIT’s Technology Licensing Office presented a World Congress webinar on innovations in machine learning and the challenges associated with protecting computer invented innovations. Charley and Daniel explored current practices and strategies to protect AI innovations and discussed emerging barriers against naming computers […]

Oxford University Press Publishes Firm Article on U.S. Supreme Court Holds that U.S. States are Immune From Federal Copyright Infringement Claims in Case Involving Blackbeard’s Flagship

Abstract Allen v Cooper, No 18-877, 140 S Ct 994, 23 March 2020 Thirty years ago, the U.S. Congress passed two nearly identical bills designed to strip US states of their sovereign immunity from claims of patent and copyright infringement—the Patent Remedy Act (PRA) and Copyright Remedy Clarification Act (CRCA). Almost 10 years later, in […]